Related Experiment Video
Updated: Jan 22, 2026

Recording Gamma Band Oscillations in Pedunculopontine Nucleus Neurons
Published on: September 14, 2016
The Modulation of Gamma Oscillations by Methamphetamine in Rat Hippocampal Slices
Yanan Li1,2, Xin'e Xie2, Hang Xing2,3
1The Second Affiliated Hospital, Xinxiang Medical University, Xinxiang, China.
Abstract:
Gamma frequency oscillations (γ, 30-100 Hz) have been suggested to underlie various cognitive and motor functions. The psychotomimetic drug methamphetamine (MA) enhances brain γ oscillations associated with changes in psychomotor state. Little is known about the cellular mechanisms of MA modulation on γ oscillations. We explored the effects of multiple intracellular kinases on MA modulation of γ induced by kainate in area CA3 of rat ventral hippocampal slices. We found that dopamine receptor type 1 and 2 (DR1 and DR2) antagonists, the serine/threonine kinase PKB/Akt inhibitor and N-methyl-D-aspartate receptor (NMDAR) antagonists prevented the enhancing effect of MA on γ oscillations, whereas none of them affected baseline γ strength. Protein kinase A, phosphoinositide 3-kinase and extracellular signal-related kinases inhibitors had no effect on MA. We propose that the DR1/DR2-Akt-NMDAR pathway plays a critical role for the MA enhancement of γ oscillations. Our study provides an new insight into the mechanisms of acute MA on MA-induced psychosis.
Insights
Methamphetamine (MA) enhances gamma (γ) oscillations, crucial for cognition. Researchers found that blocking dopamine and NMDA receptors, and inhibiting the Akt kinase, prevented this MA effect, revealing key cellular mechanisms.
Area of Science:
- Neuroscience
- Psychopharmacology
- Cellular mechanisms
Background:
- Gamma frequency oscillations (γ, 30-100 Hz) are vital for cognitive and motor functions.
- Methamphetamine (MA) enhances brain γ oscillations, linked to psychomotor changes.
- The precise cellular mechanisms underlying MA's modulation of γ oscillations remain unclear.
Purpose of the Study:
- To investigate the cellular mechanisms by which MA modulates γ oscillations.
- To explore the role of intracellular kinases in MA's enhancement of γ oscillations.
- To elucidate the pathway involved in MA's effects on γ oscillations in the hippocampus.
Main Methods:
- Utilized rat ventral hippocampal slices (area CA3) and kainate-induced γ oscillations.
- Administered antagonists for dopamine receptor type 1 and 2 (DR1/DR2) and N-methyl-D-aspartate receptors (NMDAR).
- Tested inhibitors for various intracellular kinases, including PKB/Akt, Protein Kinase A, phosphoinositide 3-kinase, and extracellular signal-related kinases.
Main Results:
- DR1/DR2 antagonists, PKB/Akt inhibitor, and NMDAR antagonists blocked MA's enhancement of γ oscillations.
- None of the tested antagonists or inhibitors affected baseline γ oscillation strength.
- Inhibitors of Protein Kinase A, phosphoinositide 3-kinase, and extracellular signal-related kinases did not impact MA's effect on γ oscillations.
Conclusions:
- The dopamine receptor (DR1/DR2)-Akt-NMDAR pathway is critical for MA-induced enhancement of γ oscillations.
- This study offers new insights into the acute cellular mechanisms of MA's effects on psychosis.
- Understanding these pathways may inform strategies for managing MA-induced neurological alterations.
Related Concept Videos
Oscillations In An LC Circuit
Forced Oscillations
Damped Oscillations
Although friction and other non-conservative...
Oscillations about an Equilibrium Position
RLC Circuit as a Damped Oscillator
Consider a series RLC circuit. Here, the presence of resistance in the circuit leads to energy loss due to joule heating in the resistance. Therefore, the total electromagnetic energy in the circuit is no longer constant and decreases with time. Since the magnitude of charge, current, and potential difference continuously decreases, their oscillations are said to be damped. This is...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

